Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019 - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …

Histone modifications and non-coding RNAs: mutual epigenetic regulation and role in pathogenesis

IV Bure, MV Nemtsova, EB Kuznetsova - International Journal of …, 2022 - mdpi.com
In the last few years, more and more scientists have suggested and confirmed that
epigenetic regulators are tightly connected and form a comprehensive network of regulatory …

Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities

S Müller-Dott, E Tsirvouli, M Vazquez… - Nucleic acids …, 2023 - academic.oup.com
Gene regulation plays a critical role in the cellular processes that underlie human health and
disease. The regulatory relationship between transcription factors (TFs), key regulators of …

METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial–mesenchymal transition of renal tubular cells in diabetic kidney disease

Z Xu, K Jia, H Wang, F Gao, S Zhao, F Li, J Hao - Cell death & disease, 2021 - nature.com
Abstract Histone deacetylase 5 (HDAC5) belongs to class II HDAC subfamily and is reported
to be increased in the kidneys of diabetic patients and animals. However, little is known …

Epigenetic regulation of microRNAs in cancer: shortening the distance from bench to bedside

MJ Pajares, E Alemany-Cosme, S Goñi… - International Journal of …, 2021 - mdpi.com
Cancer is a complex disease involving alterations of multiple processes, with both genetic
and epigenetic features contributing as core factors to the disease. In recent years, it has …

Histone deacetylase inhibitors to overcome resistance to targeted and immuno therapy in metastatic melanoma

M Yeon, Y Kim, HS Jung, D Jeoung - Frontiers in cell and …, 2020 - frontiersin.org
Therapies that target oncogenes and immune checkpoint molecules constitute a major
group of treatments for metastatic melanoma. A mutation in BRAF (BRAF V600E) affects …

A systematic review of progress toward unlocking the power of epigenetics in NSCLC: Latest updates and perspectives

A Sulewska, L Pilz, C Manegold, R Ramlau… - Cells, 2023 - mdpi.com
Epigenetic research has the potential to improve our understanding of the pathogenesis of
cancer, specifically non-small-cell lung cancer, and support our efforts to personalize the …

[HTML][HTML] The regulatory role of autophagy-related miRNAs in lung cancer drug resistance

M Shahverdi, K Hajiasgharzadeh, AD Sorkhabi… - Biomedicine & …, 2022 - Elsevier
Autophagy is conserved cellular machinery that degrades un-usable proteins and cellular
components and has a crucial role in the pathogenesis and drug resistance of various …

Insights into the function and clinical application of HDAC5 in cancer management

J Yang, C Gong, Q Ke, Z Fang, X Chen, M Ye… - Frontiers in …, 2021 - frontiersin.org
Histone deacetylase 5 (HDAC5) is a class II HDAC. Aberrant expression of HDAC5 has
been observed in multiple cancer types, and its functions in cell proliferation and invasion …

Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment

X Huang, B Guo, S Liu, J Wan, HE Broxmeyer - Nature communications, 2018 - nature.com
Enhancement of hematopoietic stem cell (HSC) homing and engraftment is clinically critical,
especially for cord blood (CB) hematopoietic cell transplantation. Here we report that …